Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
OwnerThomas Cantorinventor
Life of this patent
Estimating the term…
Abstract
The present invention relates to kits for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism. The kit provides means to measure the level of a PTH agonist and a PTH antagonist in a patient, and it further provides means for administering a PTH suppressing therapeutic to the patient so as to reduce the level of a PTH agonist and minimize the level of parathyroid hormone antagonist.
Claims18
1-42. (canceled)
A kit for monitoring and guiding therapeutic suppression of parathyroid hormone in a renal patient having secondary hyperparathyroidism, the kit comprising:
- a) means for monitoring the level of a parathyroid hormone (PTH) agonist in the patient;
- b) means for monitoring the level of a PTH antagonist in the patient;
- and
- c) means for administering to the patient a therapeutic that suppresses PTH agonist, whereby the amount of therapeutic administered is adjusted such that PTH agonist levels are decreased and the level of PTH antagonist is minimized.
A kit for monitoring and guiding therapeutic suppression of parathyroid hormone in a renal patient having secondary hyperparathyroidism, the kit comprising:
- means for monitoring the level of a PTH antagonist in the patient;
- and
- means for administering to the patient a therapeutic that suppresses PTH agonist, whereby the amount of therapeutic administered is adjusted such that the level of PTH antagonist in the patient is minimized.
Dependencies are inferred from the claim text.